A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective ...
Study tips from the top ranked students in some of the state’s most popular HSC subjects have revealed their secret study tips, relaxation methods and what comes next. The top ranking student in the ...
As the products of the IT industry have become ever more prevalent in our everyday lives, evidence of undesirable consequences of their use has become ever more difficult to ignore. Consequently, ...
Ty Parker isn’t selling a fairy tale. His Health Sciences/BASC/Charter football team finished the regular season 8-0, earning the No. 2 seed in the Section VI Class A playoffs, but the coach’s ...
Utility Coordination Brindley Pieters and Associates Inc. The $274.5-million design-build project completes a 25-mile beltway with a new directional system interchange that reduces bridge maintenance ...
BOSTON--(BUSINESS WIRE)--Ensoma, an in vivo hematopoietic stem cell (HSC) engineering company with a mission to advance the future of medicine through one-time therapies, today announced the closing ...
Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline Company’s Phase 1/2 Clinical ...
Making industrial chemicals like ethylene glycol — a key component in polymer production and familiar to many as antifreeze — consumes large amounts of energy and releases significant carbon dioxide ...
A team of Chinese researchers led by Prof. GAO Caixia from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences has developed two new genome editing technologies, ...
A team of Chinese researchers led by Prof. GAO Caixia from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences has developed a groundbreaking method that ...
The project is currently finalising environmental documentation and preliminary engineering with plans to move to the construction phase in the early 2030s. Credit: HDR. HDR has been chosen by the ...
Researchers in the lab of Hans-Peter Kiem, MD, PhD, at Fred Hutch Cancer Center have devised a method that could one day treat genetic hematologic disorders by correcting how the body makes blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results